Sesen Bio Inc. [NASDAQ: SESN] slipped around 0.0 points on Wednesday, while shares priced at $1.00 at the close of the session, down 0.00%. The company report on May 26, 2020 that Sesen Bio to Present at the Jefferies Virtual Healthcare Conference.
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020.
Event: Jefferies Virtual Healthcare ConferenceDate: June 2, 2020Time: 8:30 – 8:55 AM ET.
Sesen Bio Inc. stock is now -3.85% down from its year-to-date (YTD) trading value. SESN Stock saw the intraday high of $1.06 and lowest of $0.95 per share. The company’s 52-week high price is 1.54, which means current price is +170.27% above from all time high which was touched on 07/27/20.
Compared to the average trading volume of 1.21M shares, SESN reached a trading volume of 2481535 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Sesen Bio Inc. [SESN]?
H.C. Wainwright have made an estimate for Sesen Bio Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 11, 2019.
The Average True Range (ATR) for Sesen Bio Inc. is set at 0.07 The Price to Book ratio for the last quarter was 5.88, with the Price to Cash per share for the same quarter was set at 0.39.
How has SESN stock performed recently?
Sesen Bio Inc. [SESN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 20.19. With this latest performance, SESN shares gained by 42.86% in over the last four-week period, additionally plugging by 2.04% over the last 6 months – not to mention a drop of -12.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SESN stock in for the last two-week period is set at 73.97, with the RSI for the last a single of trading hit 76.33, and the three-weeks RSI is set at 71.19 for Sesen Bio Inc. [SESN]. The present Moving Average for the last 50 days of trading for this stock 0.7748, while it was recorded at 1.0038 for the last single week of trading, and 0.8595 for the last 200 days.
Sesen Bio Inc. [SESN]: Deeper insight into the fundamentals
Return on Total Capital for SESN is now -421.21, given the latest momentum, and Return on Invested Capital for the company is -1,228.08. Return on Equity for this stock declined to -1,228.08, with Return on Assets sitting at -95.16.
Reflecting on the efficiency of the workforce at the company, Sesen Bio Inc. [SESN] managed to generate an average of -$4,300,000 per employee.Sesen Bio Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.10 and a Current Ratio set at 6.10.
Earnings analysis for Sesen Bio Inc. [SESN]
With the latest financial reports released by the company, Sesen Bio Inc. posted -0.67/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -509.10%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for SESN.
Insider trade positions for Sesen Bio Inc. [SESN]
There are presently around $17 million, or 18.50% of SESN stock, in the hands of institutional investors. The top three institutional holders of SESN stocks are: TRV GP, LLC with ownership of 4,841,591, which is approximately 0% of the company’s market cap and around 0.07% of the total institutional ownership; VANGUARD GROUP INC, holding 4,001,824 shares of the stock with an approximate value of $4.0 million in SESN stocks shares; and BLACKROCK INC., currently with $2.14 million in SESN stock with ownership of nearly -0.17% of the company’s market capitalization.
Positions in Sesen Bio Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 19 institutional holders increased their position in Sesen Bio Inc. [NASDAQ:SESN] by around 747,382 shares. Additionally, 21 investors decreased positions by around 1,442,729 shares, while 12 investors held positions by with 15,072,355 shares. The mentioned changes placed institutional holdings at 17,262,466 shares, according to the latest SEC report filing. SESN stock had 6 new institutional investments in for a total of 462,009 shares, while 15 institutional investors sold positions of 1,281,372 shares during the same period.